Serplulimab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer

Evaluation committee members

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by committee D.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of each evaluation committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

Chair

Raju Reddy
Interim chair, technology appraisal committee D

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager and an associate director.

Lauren Elston, Cara Gibbons, and George Millington
Technical leads

Rachel Williams and Cara Gibbons
Technical advisers

Kate Moore and Louise Jafferally
Project managers

Lorna Dunning and Ross Dent
Associate directors

ISBN: 978-1-4731-9556-1